Jörg A.
- Country
- Germany
- Department
- Klinik für Hämatologie, Onkologie und Palliativmedizin, Stuttgart Cancer Center
Research Overview
Data & Insights
Has run more than one trial at 0 of 23 partner sites.
Specializations
Acute Myeloid Leukemia and Myeloid Neoplasms
Focuses on therapeutic strategies for Acute Myeloid Leukemia and related high‑risk myeloid conditions.
- CPX‑351 in de‑novo AML
- Gemtuzumab‑Ozogamicin adjunct therapy
- MRD‑driven treatment adaptation
Emphasis on integrating novel agents into standard chemotherapy regimens.
Aggressive Lymphoid Malignancies
Investigates treatment options for high‑grade Diffuse Large B‑Cell Lymphoma and related lymphomas.
- R‑CHOP combined with BTK inhibition
- Polatuzumab‑based salvage regimens
- Mantle cell lymphoma autologous transplantation
- Classical Hodgkin lymphoma checkpoint blockade
Targets improving event‑free survival across diverse lymphoma subtypes.
Solid Tumor Therapeutics
Explores targeted and immunologic approaches for major solid cancers such as Non‑Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma.
- EGFR‑mutated NSCLC tyrosine‑kinase inhibition
- PD‑L1 blockade combined with chemotherapy in lung adenocarcinoma
- FGFR‑targeted therapy in bladder cancer
- Enfortumab vedotin plus immunotherapy in urothelial carcinoma
Aims to expand effective regimens for metastatic disease.
Pediatric Oncology
Dedicated to childhood malignancies including Acute Lymphoblastic Leukemia and Ewing Sarcoma.
- Ph‑positive ALL tyrosine‑kinase inhibitor integration
- Intensified chemotherapy for high‑risk Ewing sarcoma
- Neuroblastoma risk‑adapted protocols
- Medulloblastoma subgroup‑specific radiotherapy
Prioritizes risk‑adapted therapy and long‑term survivorship.
Supportive Care and Allergic Diseases
Addresses management of treatment‑related toxicities and allergic disorders such as chemotherapy‑induced peripheral neuropathy and seasonal allergic rhinitis.
- Neuroprotective agents for CIPN
- Allergen immunotherapy for birch pollen allergy
- Vision preservation in central retinal artery occlusion
- Pain mitigation strategies during oncology care
Integrates quality‑of‑life improvements alongside oncologic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.